Assessing Generate Biomedicines (GENB) Valuation As Losses Mount And Price To Book Sits At 3.3x

Simply Wall St.06-01

AdvertisementStock performance snapshot Generate Biomedicines (GENB) has drawn attention after recent trading, with the stock last closing at $13.12 and showing a mixed pattern over different periods,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2640952990?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-06-01 19:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640952990","market":"hk","top_or_hot":-1,"title":"Assessing Generate Biomedicines (GENB) Valuation As Losses Mount And Price To Book Sits At 3.3x","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementStock performance snapshot Generate Biomedicines (GENB) has drawn attention after recent trading, with the stock last closing at $13.12 and showing a mixed pattern over different periods,...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-genb/generate-biomedicines/news/assessing-generate-biomedicines-genb-valuation-as-losses-mou\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Generate Biomedicines (GENB) Valuation As Losses Mount And Price To Book Sits At 3.3x</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Generate Biomedicines (GENB) Valuation As Losses Mount And Price To Book Sits At 3.3x\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-01 19:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-genb/generate-biomedicines/news/assessing-generate-biomedicines-genb-valuation-as-losses-mou><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementStock performance snapshot Generate Biomedicines (GENB) has drawn attention after recent trading, with the stock last closing at $13.12 and showing a mixed pattern over different periods,...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-genb/generate-biomedicines/news/assessing-generate-biomedicines-genb-valuation-as-losses-mou\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GENB","symbol_name":"Generate Biomedicines","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-genb/generate-biomedicines/news/assessing-generate-biomedicines-genb-valuation-as-losses-mou","article_id":"2640952990","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-genb/generate-biomedicines/news/assessing-generate-biomedicines-genb-valuation-as-losses-mou","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2640952990","pubTimestamp":1780312753,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Stock performance snapshot\nGenerate Biomedicines (GENB) has drawn attention after recent trading, with the stock last closing at $13.12 and showing a mixed pattern over different periods, including a small move over the past month and a gain over the past 3 months.\nSee our latest analysis for Generate Biomedicines.\nRecent trading has been choppy, with a 7 day share price return of down 9.7% contrasting with a 90 day share price return of up 10.0%. This suggests short term momentum is cooling...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"GENB":"Generate Biomedicines","BK4139":"生物科技"},"translate_title":"随着亏损增加且市净率为3.3倍，评估Generate Biomedicines(GENB)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GENB":1.5},"content_text":"AdvertisementStock performance snapshot Generate Biomedicines (GENB) has drawn attention after recent trading, with the stock last closing at $13.12 and showing a mixed pattern over different periods, including a small move over the past month and a gain over the past 3 months. See our latest analysis for Generate Biomedicines. Recent trading has been choppy, with a 7 day share price return of down 9.7% contrasting with a 90 day share price return of up 10.0%. This suggests short term momentum is cooling after earlier strength. If you are curious about what else is moving in AI driven healthcare, this is a good moment to widen your watchlist and review 39 healthcare AI stocks With Generate Biomedicines reporting revenue of $30.299 million alongside a net loss of $265.441 million and a recent close at $13.12, the key question is whether this represents a genuine opportunity or if the market is already fully valuing its prospects. Preferred Price-to-Book Multiple of 3.3x: Is it justified? On a P/B basis, Generate Biomedicines trades at 3.3x book value, which sits above the broader US biotechs average but below its closer peer group. P/B compares a company’s market value to its net assets, which can matter for early stage biotechs that are still reporting losses rather than steady earnings. For Generate Biomedicines, the share price currently implies a richer valuation than the wider US biotechs industry, where the average P/B is 2.6x. At the same time, the stock sits at a discount to its immediate peers, which trade on an average P/B of 5.8x. This suggests the market assigns it a middle of the pack valuation within that peer set. See what the numbers say about this price — find out in our valuation breakdown. Result: Price-to-book of 3.3x (ABOUT RIGHT) However, there are clear risks, including the company’s US$265.441 million net loss and its reliance on a still developing generative biology platform to support its pipeline ambitions. Find out about the key risks to this Generate Biomedicines narrative. Next Steps With mixed signals across valuation, losses and future potential, it makes sense to check the underlying data yourself and decide where you stand. To see both sides clearly, review the 3 key rewards and 3 important warning signs Looking for more investment ideas? If you are serious about building a stronger portfolio, do not stop with a single stock. Use targeted screeners to spot opportunities that others overlook.  Supercharge your hunt for quality by checking companies that combine attractive pricing with robust fundamentals through the 46 high quality undervalued stocks. Protect your capital by focusing on businesses with healthier finances using the solid balance sheet and fundamentals stocks screener (46 results). Get ahead of the crowd by scanning lesser known opportunities with solid metrics through the screener containing 22 high quality undiscovered gems.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2640952990","isCrawlerRequest":true}